Pfizer/BioNTech Covid-19 vaccine safe for primary schoolkids

Clinical trial results have demonstrated that the Pfizer-BioNTech Covid-19 vaccine is safe to be used in children aged five to 11 years. — AFP

Pfizer and BioNTech said on Sept 20 (2021) that clinical trial results showed their Covid-19 vaccine is safe and produces a robust immune response in children aged five to 11.

The vaccine would be administered at a lower dosage than for people over 12, they said.